March 7, 2022 — Popular blood stress drugs might add years to the lives of sufferers with pancreatic most cancers, a notoriously tough-to-treat most cancers with low survival charges, new analysis suggests.

These medication, often known as angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), decrease blood stress by enjoyable veins and arteries and permitting the center to pump blood extra simply.

Studies in animals have proven that these drugs may sluggish the expansion of pancreatic most cancers. Several small research in folks recommend the identical factor, however the numbers of sufferers included have been too small to attract agency conclusions.

In the brand new research, researchers examined information on 3.7 million adults from Italy, and recognized 8,158 folks recognized with pancreatic most cancers between 2003 and 2011.

The research, printed final month within the journal BMC Cancer, discovered that the overwhelming majority of those sufferers (86%) died inside about 6 months of their analysis.

But sufferers who took ARBs after their pancreatic most cancers analysis had a 20% decrease threat of dying, in comparison with related sufferers who didn’t take ARBs.

In a smaller group of sufferers who had surgical procedure for his or her most cancers, ARB customers had a 28% decrease threat of dying.

Also, sufferers with pancreatic most cancers who took ACE inhibitors had a 13% decrease threat of dying within the first 3 years after analysis, however this profit shrank later.

But “ARBs and ACE inhibitors nonetheless must be thought-about experimental therapies for pancreatic most cancers,” cautions research investigator Scott Keith, PhD, of Thomas Jefferson University in Philadelphia.

Timothy Pawlik, MD, PhD, additionally cautions to not soar to agency conclusions based mostly on this research.

“While provocative, the info can’t be thought-about conclusive,” says Pawlik, with the Ohio State University Comprehensive Cancer Center.

“The research is retrospective, which makes it prone to choice and therapy bias. In addition, the info have been derived from an administrative well being care database, which could be infamous for missing granular scientific information,” he factors out.

Pawlik additionally notes that research evaluating the advantages of blood stress drugs on most cancers threat and outcomes is combined. Several earlier research, for example, recommend ACE inhibitors and ARBs might shield towards malignancies comparable to colorectal most cancers, whereas different information suggests a potential hyperlink between ACE inhibitors and a better threat for sure cancers, comparable to lung most cancers.

The post Blood Pressure Meds May Prolong Life in Pancreatic Cancer appeared first on Healthy and Slim Life.

Four months. From the time my dad was identified with pancreatic most cancers to the time that he died was simply 4 months. It’s exhausting to consider that greater than 21 years have handed since that have and the way it modified my private {and professional} ardour to create a world the place pancreatic most cancers sufferers can thrive. And whereas we nonetheless have quite a lot of work to do, there have been steady incremental advances over the past 20 years — most just lately, developments within the function of genetic and tumor testing for sufferers and members of the family — that give me purpose to be very hopeful about what lies forward and the chance to considerably change affected person outcomes.

Like most, I knew little or no about pancreatic most cancers earlier than my father’s prognosis, however as quickly as I heard these phrases, I went on-line and rapidly discovered there was a lack of knowledge, assets, and analysis dedicated to the illness. Back then, little or no was identified about pancreatic most cancers — solely a handful of researchers have been learning it and the 5-year survival charge was simply 4%. I used to be offended that my dad and 1000’s of different sufferers got no hope. They have been provided no therapy choices and despatched house to get their affairs so as.

That hopelessness and anger impressed me to take motion, and shortly after my father died, I found the Pancreatic Cancer Action Network (PanCAN) in 1999, a newly fashioned group on the time. I started my journey with PanCAN as a volunteer and was employed because the group’s first full-time worker in 2000. In my function as president and CEO, I’m honored to have the chance to work with the pancreatic most cancers neighborhood and I’ve watched PanCAN turn into the driving drive for accelerating progress: funding over $149M in pancreatic most cancers analysis thus far, supporting sufferers and their households by way of our Patient Services program, and constructing a passionate and energetic neighborhood of volunteers and advocates who’re elevating funds and consciousness to drive our mission.

I’ve all the time been impressed by affected person advocates, witnessing firsthand what sufferers and their households do for PanCAN in honor of their family members to vary the longer term for pancreatic most cancers sufferers, however I had a newfound realization in regards to the significance of affected person advocates once I grew to become a affected person myself.

In 2018, I used to be identified with breast most cancers, found throughout a routine mammogram. I contemplate myself exceptionally lucky — my prognosis was early-stage due to breast most cancers screening — and after surgical procedure, I used to be cancer-free. I additionally had genetic testing performed, which is normal for breast most cancers sufferers, to find out what remedies may be greatest for me and to grasp my household’s danger of sure sorts of most cancers. After that have, I used to be so extremely grateful to the breast most cancers advocates who had come earlier than me and pushed for early detection and higher remedies for the illness.

This expertise strengthened how necessary it’s to rejoice the incremental advances being made yearly for pancreatic most cancers sufferers as a result of I do know with every bit of recent data, we unlock the mysteries of this difficult illness.

Due to advances in analysis, it’s now beneficial that each one pancreatic most cancers sufferers get genetic testing for inherited most cancers mutations and biomarker testing of their tumor to find out their greatest therapy choices. And for the primary time, new tips launched by the National Comprehensive Cancer Network (NCCN) point out that understanding your genetic danger could also be necessary for members of the family who’ve had just one first-degree relative identified with pancreatic most cancers. It is necessary to grasp your danger, keep knowledgeable, and be your personal greatest advocate.

November is Pancreatic Cancer Awareness Month and PanCAN is emphasizing the significance of testing for each sufferers and their households. Knowledge is energy, and we would like folks to take three easy steps that would save their lives: discuss, check, and take management.

For first-degree family of pancreatic most cancers sufferers, we suggest that you just discuss to your physician or genetic counselor that can assist you perceive whether or not you must have genetic testing. PanCAN Patient Services will help you put together for that dialog.

For these already identified with pancreatic most cancers, PanCAN strongly recommends genetic testing for inherited mutations as quickly as doable after prognosis, which will help inform members of the family of their very own danger in addition to doubtlessly impression the affected person’s therapy choices. We additionally suggest that each one pancreatic most cancers sufferers obtain biomarker testing of their tumor tissue by way of a precision drugs service like PanCAN’s Know Your Tumor to grasp if their tumor biology might assist inform therapy choices.

Today, pancreatic most cancers sufferers and their households have extra data and choices than when my father was identified with the illness. And I’ve little question that with the continued relentless effort of PanCAN advocates, there will likely be a day sooner or later when somebody is identified with pancreatic most cancers early as a result of there may be an early detection check and cured as a result of there are new remedies. In the meantime, every day we’re taking steps that speed up the speed of progress. Talk, check, and take management. Three easy steps that present data and empowerment now for pancreatic most cancers sufferers and their households. Learn extra at pancan.org.

Julie Fleshman is president and CEO of the Pancreatic Cancer Action Network.

This article is a part of WebMD’s contributor program, which lets folks and organizations outdoors of WebMD submit articles for consideration on our website. Have an thought for a submission? Email us at [email protected]

The post Talk, Test, and Take Control: Living With Pancreatic Cancer appeared first on Healthy and Slim Life.

WEDNESDAY, Nov. 10, 2021 (HealthDay News) — Researchers have recognized two beforehand unrecognized signs of pancreatic most cancers — a discovery that may assist with earlier detection and enhance extraordinarily low survival numbers, they are saying.

“When pancreatic most cancers is recognized earlier, sufferers have the next probability of survival. It is feasible to diagnose sufferers once they go to their GP, however each sufferers and GPs want to pay attention to the signs related to pancreatic most cancers,” stated research writer Weiqi Liao, an information scientist at Britain’s University of Oxford.

Along with confirming 21 beforehand recognized indicators of pancreatic most cancers, the brand new research pinpoints two new signs — feeling thirsty and having darkish urine — related to the lethal illness.

It additionally exhibits that sufferers usually have some signs of the illness as much as a yr earlier than their prognosis, and different important signs three months earlier than prognosis.

Most pancreatic most cancers sufferers are recognized at a late stage and the illness has the bottom survival numbers amongst all frequent cancers. In the United States, the five-year survival charge for pancreatic most cancers sufferers is about 10%, in accordance with the American Cancer Society.

The research included greater than 24,000 sufferers who had been recognized with pancreatic most cancers in England between 2000 and 2017.

Yellowing of the pores and skin (jaundice) and bleeding within the abdomen or gut had been the 2 severe signs most related to pancreatic ductal adenocarcinoma (PDAC), the commonest sort of pancreatic most cancers, and pancreatic neuroendocrine neoplasms (PNEN), a rarer type of pancreatic most cancers.

The two newly recognized signs — thirst and darkish urine — had been related to PDAC, in accordance with the research. The outcomes had been offered nearly Monday at a U.Ok. National Cancer Research Institute assembly.

Other signs linked with PDAC embody: issues swallowing, diarrhea, change in bowel habits, vomiting, indigestion, belly mass, belly ache, weight reduction, constipation, fats in stool, belly swelling, nausea, flatulence, heartburn, fever, tiredness, urge for food loss, itching and again ache.

Other signs related to PNEN embody: diarrhea, change in bowel habits, vomiting, indigestion, belly mass, belly ache and weight reduction.

“These new findings allow us to conduct additional work on understanding signs that might recommend pancreatic most cancers. This will assist GPs to make choices about who to refer for pressing assessments, particularly when sufferers have a number of seemingly non-specific signs,” Liao stated in an institute information launch.

Studies offered at conferences are usually thought of preliminary till revealed in a peer-reviewed medical journal.

More info

The American Cancer Society has extra on pancreatic most cancers.

SOURCE: National Cancer Research Institute, information launch, Nov. 8, 2021

The post Two New Symptoms That Could Point to Pancreatic Cancer appeared first on Healthy and Slim Life.

MONDAY, Oct. 25, 2021 (HealthDay News) — In his work with sufferers who’ve pancreatic most cancers, Dr. Srinivas Gaddam was bothered by one thing that he was seeing.

“There are some sufferers that you could’t cease fascinated with as a result of they’ve left a mark on you and also you strive your finest to show issues round, however there’s solely a lot you are able to do,” stated Gaddam, who stated he had discovered himself caring for just a few sufferers who had been very younger.

“We knew that there was a development [of younger patients] in colon most cancers, however we did not find out about pancreas most cancers. So, I made a decision to see if there was an actual development. Was it simply that I occurred to see these few younger sufferers disproportionate to everyone else within the discipline,” stated Gaddam, who’s an assistant professor of drugs within the Karsh Division of Gastroenterology and Hepatology at Cedars-Sinai Medical Center in Los Angeles. “It seems to be true.”

What Gaddam and the opposite researchers seen is that numbers of individuals recognized with pancreatic most cancers, generally known as a silent killer as a result of it is harder to detect in its early phases, have been rising the previous 20 years for each women and men.

Even extra surprisingly, they discovered the illness was disproportionately rising in youthful ladies, these underneath age 55, and particularly amongst these aged 15 to 34, although the pattern dimension was small. Pancreatic most cancers has usually been extra frequent in males.

If the present development continues, researchers stated pancreatic most cancers amongst ladies aged 15 to 34 would develop to be 400% of that skilled by males of the identical ages by 2040.

“This research does not reply why, it shines a light-weight on the truth that it is rising and it is rising disproportionate to that of males,” Gaddam stated.

Without realizing why, the reply for now could be left open to hypothesis. It might be that girls have a disproportionately excessive publicity to some environmental threat consider current many years that researchers do not perceive but, Gaddam stated.

An epidemic if not caught early

While the charges are rising extra quickly in ladies youthful than 55, they’re nonetheless very low in younger people, in accordance with the analysis, which was revealed on-line Oct. 24 within the Journal of the American Medical Association. The analysis was offered concurrently on the American College of Gastroenterology’s annual assembly, which is being held each in Las Vegas and on-line.

To research the problem, researchers gathered pancreatic most cancers incidence charges per 100,000 folks for 2000 to 2018 from the Surveillance Epidemiology and End Results (SEER) database, which collects information from most cancers registries that cowl 37% of the U.S. inhabitants. They discovered 283,817 instances in ladies and men throughout these years.

The issue in diagnosing pancreatic most cancers is that there isn’t a stable screening take a look at to determine it early and sufferers haven’t got signs till fairly late within the illness, Gaddam stated.

Despite large advances in most cancers detection and therapy for different sorts of most cancers, the five-year survival charge of pancreatic most cancers has improved from 3% to only 10% over the previous a number of many years, Gaddam stated.

Risk components embrace household historical past.

“We do have a well-defined, however a small, group of high-risk sufferers. For these, we are likely to display yearly. We are likely to do MRI, CT scans and endoscopic ultrasound,” Gaddam defined. “These are totally different modalities of testing on these sufferers to detect most cancers, however for the overwhelming majority of the final inhabitants, actually not too many issues to go by.”

Risk components can embrace weight problems or smoking, however they aren’t pretty robust predictors for pancreatic most cancers, Gaddam stated. Doctors additionally search for jaundice with no belly ache, profound, unexplained weight reduction or a brand new prognosis of diabetes.

Questions stay

“Obviously not all causes of a brand new prognosis of diabetes are most cancers, or not everybody that has weight reduction has pancreas most cancers. So, we’ve to be actually cautious about that, however we search for these delicate tell-tale indicators after we speak to our sufferers,” Gaddam stated.

Many folks with pancreatic most cancers have very imprecise signs to start with, comparable to minor belly discomfort or indigestion, stated Dr. Sajan Nagpal, an assistant professor within the division of drugs on the University of Chicago. Nagpal was not concerned on this research.

Longstanding diabetes and continual pancreatitis are different threat components.

By the time the most cancers is detected, 80% of sufferers are now not eligible for surgical procedure, the one technique to treatment the most cancers, Nagpal stated. Other remedies embrace chemotherapy and radiation.

“The precise variety of folks which can be efficiently capable of get surgical procedure is even smaller, which is why the outcomes from pancreatic most cancers stay poor,” Nagpal stated. “It could be nice if we might determine sufferers at an earlier stage, as a result of that will imply sufferers would qualify for surgical procedure and we might enhance outcomes in these sufferers.”

Nagpal advised extra analysis, utilizing bigger databases and hospital-based outpatient oncology information to probably corroborate this research and supply details about why this could be occurring.

Gaddam additionally known as for extra analysis.

“I believe this reveals a probably alarming development and we have to put, as a society, extra funding into this space to stem this rise,” Gaddam stated. “I believe it requires extra analysis, extra analysis {dollars}, extra ladies needs to be talking out for analysis on this space. And I’d say if there’s anyone on the market that is nervous about pancreas most cancers of their household, or in the event that they see a development, they need to speak to their physician about it.”

More info

The Pancreatic Cancer Action Network has extra on pancreatic most cancers.

SOURCES: Srinivas Gaddam, MD, gastroenterologist and assistant professor, drugs, Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles; Sajan Nagpal, MBBS, assistant professor, drugs, and director, Pancreas Clinic, University of Chicago; Journal of the American Medical Association, Oct. 24, 2021, on-line; Oct. 24, 2021, presentation, American College of Gastroenterology annual assembly, Las Vegas

The post Why Are Cases of Pancreatic Cancer Rising in Young Women? appeared first on Healthy and Slim Life.